tradingkey.logo

Zoetis Inc

ZTS
View Detailed Chart

156.320USD

+0.889+0.57%
Close 04/30, 16:00ETQuotes delayed by 15 min
70.11BMarket Cap
28.20P/E TTM

Zoetis Inc

156.320

+0.889+0.57%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.57%

5 Days

+3.58%

1 Month

-4.16%

6 Months

-14.46%

Year to Date

-4.06%

1 Year

-1.83%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 20 analysts
BUY
Current Rating
199.619
Target Price
28.43%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

162
Total
6
Median
8
Average
Company name
Ratings
Analysts
Zoetis Inc
ZTS
20
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
33

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(2)
Buy(4)
Indicators
Sell(1)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
2.190
Neutral
RSI(14)
51.472
Neutral
STOCH(KDJ)(9,3,3)
89.501
Overbought
ATR(14)
5.111
Low Volatility
CCI(14)
156.169
Buy
Williams %R
4.782
Overbought
TRIX(12,20)
-0.303
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
153.136
Buy
MA10
150.717
Buy
MA20
151.912
Buy
MA50
159.283
Sell
MA100
164.347
Sell
MA200
174.277
Sell

News

More news coming soon, stay tuned...

Company

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company codeZTS
CompanyZoetis Inc
CEOMs. Kristin C. Peck
Websitehttps://www.zoetis.com/